ConductScience.org, home

Paper41968324

Poor adherence to second-line antiretroviral therapy and its contributing factors among people living with HIV in Addis Ababa, Ethiopia.

Feyissa BB and 3 others. AIDS Res Ther, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Poor adherence to second-line antiretroviral therapy and its contributing factors among people living with HIV in Addis Ababa, Ethiopia. Papers, record 41968324. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41968324

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Poor adherence to second-line antiretroviral therapy and its contributing factors among people living with HIV in Addis Ababa, Ethiopia.
PubMed
Journal
AIDS Res Ther
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feyissa BBBekelech Bayou
2Sisay AAbay
3Yalew AAnteneh
4Setswe GGeoffrey

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
Anti-HIV AgentsMajor topic
Medication AdherenceMajor topic
Drug MonitoringMajor topic
Humans
Ethiopia
Female
Adult
Male
Viral Load
Middle Aged
Young Adult
Risk Factors
Adolescent
Adherence Interventions
Counseling

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
RD/PY-597/2024Addis Ababa UniversityPubMed

Source PubMed

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139576774Factors associated with viral load re-suppression after enhanced adherence counseling among people living with HIV with an initial high viral load result in selected Nigerian states.PLOS Glob Public Health2024https://conductscience.org/library/papers/39576774PubMed
230462188Persistent Low-level Viremia Predicts Subsequent Virologic Failure: Is It Time to Change the Third 90?Clin Infect Dis2019https://conductscience.org/library/papers/30462188PubMed
330665440What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.AIDS Res Ther2019https://conductscience.org/library/papers/30665440PubMed
422427821Virologic failure of protease inhibitor-based second-line antiretroviral therapy without resistance in a large HIV treatment program in South Africa.PLoS One2012https://conductscience.org/library/papers/22427821PubMed
531886271Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study.Biomed Res Int2019https://conductscience.org/library/papers/31886271PubMed
631182074Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal.BMC Public Health2019https://conductscience.org/library/papers/31182074PubMed
712349391The Joint United Nations Programme on HIV / AIDS (UNAIDS). Project update.Pac AIDS Alert Bull1999https://conductscience.org/library/papers/12349391PubMed
818237359Medication compliance and persistence: terminology and definitions.Value Health2008https://conductscience.org/library/papers/18237359PubMed
933603348Adherence and Its Associated Factors Among Adult HIV-Infected Patients on Antiretroviral Therapy in South Western Ethiopia, 2020.Patient Prefer Adherence2021https://conductscience.org/library/papers/33603348PubMed
1036974512Virological failure and its predictors among human immunodeficiency virus infected individuals on second line antiretroviral treatment in North-East Ethiopia, 2021.Pharmacoepidemiol Drug Saf2023https://conductscience.org/library/papers/36974512PubMed
1138652716Second-line anti-retroviral treatment failure and its predictors among patients with HIV in Ethiopia: A systematic review and meta-analysis.PLOS Glob Public Health2024https://conductscience.org/library/papers/38652716PubMed
1233882938Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.AIDS Res Ther2021https://conductscience.org/library/papers/33882938PubMed
1335416596Burden and Associated Factors of Virological Failure Among People Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.AIDS Behav2022https://conductscience.org/library/papers/35416596PubMed
1431462291Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study.AIDS Res Ther2019https://conductscience.org/library/papers/31462291PubMed
1538157133Non-Adherence to Anti-Retroviral Therapy Among Adult People Living with HIV in Ethiopia: Systematic Review and Meta-Analysis.AIDS Behav2024https://conductscience.org/library/papers/38157133PubMed
1637501982
Adherence to antiretroviral therapy and associated factors among human immunodeficiency -positive patients accessing treatment at health centers in East Gojjam Zone, Northwest Ethiopia, 2019: Community-based cross-sectional study.
Heliyon2023https://conductscience.org/library/papers/37501982PubMed
1739052562Incidence and influencing factors related to social isolation among HIV/AIDS patients: Protocol for a systematic review and meta-analysis.PLoS One2024https://conductscience.org/library/papers/39052562PubMed
1832373359
Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia, 2019: Retrospective Cohort Study.
AIDS Res Treat2020https://conductscience.org/library/papers/32373359PubMed
1933308294Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis.Syst Rev2020https://conductscience.org/library/papers/33308294PubMed
2037014900Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study.PLoS One2023https://conductscience.org/library/papers/37014900PubMed

See all 26 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41968324

GET https://conductscience.org/api/papers/v1/41968324/references?page=2